Artwork

MTPConnect에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 MTPConnect 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Improving Workforce Skills: GSK Australia Joins REDI with new PhD Graduate Innovation Program!

27:26
 
공유
 

Manage episode 307778377 series 3009792
MTPConnect에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 MTPConnect 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

For this episode, we’re exploring the incredible benefits that can flow from connecting PhD graduates with industry. By giving researchers real-world experiences in research-intensive organisations, we can drive better commercialisation outcomes.

And it’s exactly what we’re doing as a core component of our ‘Researcher Exchange and Development within Industry’ (REDI) program - in partnership with pharmaceutical company GSK. GSK is one of the largest pharmaceutical companies in the world researching, developing and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. The company has operations in Australia which employ 1,500 people in Sydney and Melbourne. GSK Australia has developed a new PhD graduate program to facilitate the cross pollination of scientific, academic research expertise with that of the Pharmaceutical Industry. The MTPConnect podcast team of Caroline Duell and Dr Rebecca Tunstall speak to GSK’s Head of Human Resources - Australia & New Zealand David Fitz-Gerald and GSK’s Director of Regulatory Affairs for Australia and New Zealand Dr Carolyn Tucek-Szabo about the launch of the new GSK PhD Graduate Innovation Program, supported by REDI over the next three years. The 12-month placement program, which builds on GSK’s successful Industry Based Learning program for undergraduate students, is open now for applications and will enable six PhD graduates to join GSK Australia assigning them to lead on core projects in areas such as early product development, medical affairs and regulatory affairs. The company is currently developing novel medicines in immuno-oncology, immuno-inflammatory, HIV, and infectious diseases (including COVID-19 therapy areas) so it’s an exciting time to throw off your lab coat to learn about industry career options. Apply by 2 December at GSK Australia’s website: https://au.gsk.com/en-au/careers/phd-graduates-and-post-doc-researchers/

  continue reading

203 에피소드

Artwork
icon공유
 
Manage episode 307778377 series 3009792
MTPConnect에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 MTPConnect 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

For this episode, we’re exploring the incredible benefits that can flow from connecting PhD graduates with industry. By giving researchers real-world experiences in research-intensive organisations, we can drive better commercialisation outcomes.

And it’s exactly what we’re doing as a core component of our ‘Researcher Exchange and Development within Industry’ (REDI) program - in partnership with pharmaceutical company GSK. GSK is one of the largest pharmaceutical companies in the world researching, developing and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. The company has operations in Australia which employ 1,500 people in Sydney and Melbourne. GSK Australia has developed a new PhD graduate program to facilitate the cross pollination of scientific, academic research expertise with that of the Pharmaceutical Industry. The MTPConnect podcast team of Caroline Duell and Dr Rebecca Tunstall speak to GSK’s Head of Human Resources - Australia & New Zealand David Fitz-Gerald and GSK’s Director of Regulatory Affairs for Australia and New Zealand Dr Carolyn Tucek-Szabo about the launch of the new GSK PhD Graduate Innovation Program, supported by REDI over the next three years. The 12-month placement program, which builds on GSK’s successful Industry Based Learning program for undergraduate students, is open now for applications and will enable six PhD graduates to join GSK Australia assigning them to lead on core projects in areas such as early product development, medical affairs and regulatory affairs. The company is currently developing novel medicines in immuno-oncology, immuno-inflammatory, HIV, and infectious diseases (including COVID-19 therapy areas) so it’s an exciting time to throw off your lab coat to learn about industry career options. Apply by 2 December at GSK Australia’s website: https://au.gsk.com/en-au/careers/phd-graduates-and-post-doc-researchers/

  continue reading

203 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생